Carclo plc
10 October 2005
For immediate release 10 October 2005
Carclo plc
('Carclo' or 'the Group')
Trading Update
An important US customer of Carclo Technical Plastics, Delphi Corporation Inc.
('Delphi'), petitioned for Chapter 11 protection on Saturday 9th October in
respect of the parent corporation and its US subsidiaries. It is anticipated
that the bankruptcy and associated reorganisation will have a limited impact on
Carclo.
Over the last three years our strategy has been to reduce our involvement with
connector moulding and with Delphi's US operations in particular. We have
successfully focussed on specialist medical customers active in diagnostic
systems where we have a market leading position. Our sales to Delphi US have
been reduced from over £7 million in 2002/03 to an annualised rate of £4.5
million in the current financial year. In anticipation of this bankruptcy filing
we had also reduced payment terms and tightly managed inventory. Accordingly,
our exposure to pre-petition Delphi is limited to a receivable of approximately
£0.5 million. Our US attorney has advised that we should expect some recovery of
this receivable but it will be some time before the amount is known. We will
therefore make an exceptional provision for the full amount in our results for
the half year to September 2005.
We expect to continue trading with Delphi during the reorganisation but will
continue with our strategy of reducing our exposure to US automotive and growing
our specialist medical business.
Excluding the impact of the Delphi receivable provision, trading results for the
half year to September 2005 are in line with our expectations. Carclo Precision
Products has had a good first half benefiting from a continuation of strong
demand for specialist lighting. Carclo Technical Plastics has seen excellent
profit growth in the Czech Republic and China which has compensated for weaker
conditions in the UK and US. Progress on new technologies such as Conductive
Inkjet Technology and soluble capsules for drug delivery has been encouraging.
The group will announce results for the half year to 30 September 2005 on Monday
5 December 2005.
- Ends -
Enquiries:
Carclo plc 01924 268040
Ian Williamson, Chief Executive
Robert Brooksbank, Finance Director
Weber Shandwick Square Mile 020 7067 0700
Richard Hews
Susanne Walker
Notes to editors
• Carclo plc is a global supplier of technical plastic products. It is a
public company whose shares are quoted on the London Stock Exchange.
• 65% of sales, on a pro forma basis, are derived from the supply of fine
tolerance, injection moulded plastic components, which are used in medical,
telecom and electronics products. This business, Carclo Technical Plastics,
operates internationally in a fast growing and dynamic market underpinned
by rapid technological development.
• 35% of sales, on a pro forma basis, are derived from the supply of
products to the automotive and aerospace industries.
• Carclo's strategy is to grow rapidly in low cost manufacturing regions
and to develop new technologies and products to underpin future growth.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.